Association of DNA Repair Genes XRCC1 and APE-1 with the Risk of Cervical Cancer in North Indian population.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 Jul 2020
Historique:
received: 14 03 2020
entrez: 27 7 2020
pubmed: 28 7 2020
medline: 7 4 2021
Statut: epublish

Résumé

Cervical cancer (CC) is one of the leading cause of death in women worldwide, HPV infection is the major risk factor in the disease development, 0and however other risk factor such as chemical carcinogens, genetic susceptibility and altered immune system are also a cause of the disease progression. In the light of the above statement we studied the base excision repair pathway (BER). We identified and studied the association of Single Nucleotide polymorphisms in the DNA repair genes of XRCC1 (Arg194Trp, Arg399G,) and APE-1Asp/148Glu to the susceptibility of cervical cancer (CC) in North Indian population. In our study of cases (n=102). Controls (n=109) were recruited from among women without cervical abnormalities. Genotypes were determined by PCR-CTPP method, Taking DNA from peripheral blood in a case control study. A positive association was observed between the polymorphisms of XRCC1 genes, that is, in codons 194 (P=0.03, odds ratio (OR) =2.39, 95% confidence interval (CI)=5.2-1.1), 280 (P=0.01, OR=4.1, 95% CI=11.5-1.3) and 399 (P=0.01, OR=3.4, 95% CI=8.6-1.3) while APE-1 genotype GG (p=0.03,odds ratio(OR)=0.2,95% confidence interval (CI)=0.97-0.004) we observed a statistically significant protective role in developing cervical cancer. Our results suggested that, XRCC1 gene is an important candidate gene for susceptibility to cervical cancer. Although the sample size was small, the present study indicate a statistical association between cervical cancer and XRCC1 SNPs. Future studies are needed that may provide a better understanding of the association between gene polymorphism and cervical carcinoma risk.<br />.

Sections du résumé

BACKGROUNDS BACKGROUND
Cervical cancer (CC) is one of the leading cause of death in women worldwide, HPV infection is the major risk factor in the disease development, 0and however other risk factor such as chemical carcinogens, genetic susceptibility and altered immune system are also a cause of the disease progression. In the light of the above statement we studied the base excision repair pathway (BER).
METHODS METHODS
We identified and studied the association of Single Nucleotide polymorphisms in the DNA repair genes of XRCC1 (Arg194Trp, Arg399G,) and APE-1Asp/148Glu to the susceptibility of cervical cancer (CC) in North Indian population. In our study of cases (n=102). Controls (n=109) were recruited from among women without cervical abnormalities. Genotypes were determined by PCR-CTPP method, Taking DNA from peripheral blood in a case control study.
RESULTS RESULTS
A positive association was observed between the polymorphisms of XRCC1 genes, that is, in codons 194 (P=0.03, odds ratio (OR) =2.39, 95% confidence interval (CI)=5.2-1.1), 280 (P=0.01, OR=4.1, 95% CI=11.5-1.3) and 399 (P=0.01, OR=3.4, 95% CI=8.6-1.3) while APE-1 genotype GG (p=0.03,odds ratio(OR)=0.2,95% confidence interval (CI)=0.97-0.004) we observed a statistically significant protective role in developing cervical cancer.
CONCLUSION CONCLUSIONS
Our results suggested that, XRCC1 gene is an important candidate gene for susceptibility to cervical cancer. Although the sample size was small, the present study indicate a statistical association between cervical cancer and XRCC1 SNPs. Future studies are needed that may provide a better understanding of the association between gene polymorphism and cervical carcinoma risk.<br />.

Identifiants

pubmed: 32711433
doi: 10.31557/APJCP.2020.21.7.2061
pmc: PMC7573399
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
X-ray Repair Cross Complementing Protein 1 0
XRCC1 protein, human 0
APEX1 protein, human EC 4.2.99.18
DNA-(Apurinic or Apyrimidinic Site) Lyase EC 4.2.99.18

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2061-2065

Références

World J Gastroenterol. 2015 Apr 28;21(16):5081-9
pubmed: 25945024
Papillomavirus Res. 2019 Jun;7:132-134
pubmed: 30954690
Andrologia. 2021 Feb;53(1):e13633
pubmed: 32365235
Inflamm Res. 2012 Apr;61(4):359-65
pubmed: 22193858
Eur J Cancer Prev. 2016 May;25(3):224-31
pubmed: 25812040
Cold Spring Harb Perspect Biol. 2013 Apr 01;5(4):a012583
pubmed: 23545420
Antioxid Redox Signal. 2005 Mar-Apr;7(3-4):367-84
pubmed: 15706084
Pathol Oncol Res. 2013 Jul;19(3):553-8
pubmed: 23539294
Clin Exp Gastroenterol. 2020 Mar 16;13:73-86
pubmed: 32214837
Zhonghua Yi Xue Za Zhi. 2013 Nov 19;93(43):3454-6
pubmed: 24423910
Mol Oncol. 2020 Sep;14(9):2124-2141
pubmed: 32408396
Cancer Res. 2007 Aug 1;67(15):7113-23
pubmed: 17671178
Asian Pac J Cancer Prev. 2020 Apr 01;21(4):1031-1037
pubmed: 32334466
J BUON. 2020 Jan-Feb;25(1):574-581
pubmed: 32277685
Int J Gynecol Cancer. 2009 Dec;19(9):1642-8
pubmed: 19955952
Int J Cancer. 2014 Dec 1;135(11):2687-96
pubmed: 24729390
Br J Biomed Sci. 2019 Jul;76(3):117-121
pubmed: 30870085
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457
pubmed: 28223433
Tumour Biol. 2014 Feb;35(2):1221-31
pubmed: 24057881
Int J Mol Epidemiol Genet. 2012;3(4):333-60
pubmed: 23205185
Data Brief. 2016 Nov 26;10:11-13
pubmed: 27942558
BMC Cancer. 2019 Jan 7;19(1):24
pubmed: 30616520
Onco Targets Ther. 2016 Nov 14;9:7019-7028
pubmed: 27895494
Int J Mol Sci. 2020 Mar 22;21(6):
pubmed: 32235701
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Mark Rector Charles (MR)

Department of Biotechnology, Era's Lucknow Medical College and Hospital, Lucknow, India.

Syed Tasleem Raza (ST)

Department of Biotechnology, Era's Lucknow Medical College and Hospital, Lucknow, India.

Rolee Sharma (R)

Department of Bioscience, Integral University Lucknow, Lucknow Uttar Pradesh, India.

Pushpendra Pratap (P)

Department of Biotechnology, Era's Lucknow Medical College and Hospital, Lucknow, India.

Ale Eba (A)

Department of Biotechnology, Era's Lucknow Medical College and Hospital, Lucknow, India.

Manvendra Singh (M)

Centre of Bio-Medical Research (CMBRL), Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH